Reyataz (Atazanavir Sulfate), For HIV Positive Pregnant Women, Gets European Labeling Update Approval
Links shared publicly online about this topic.
- 0total visits
Reyataz (Atazanavir Sulfate), For HIV Positive Pregnant Women, Gets European Labeling Update Approval
Following new data from study AI424-182 on pregnant women living with HIV, the European Commission approved a labeling update for Reyataz (atazanavir sulfate). The announcement was made by Bristol
View full resource at medicalnewstoday.com
Tags: HIV, HIV Medication, STD, Women's Health, Pregnancy, Reyataz
Most Recently Shared on November 28, 2011 at 8:59 pm By:
Reyataz (Atazanavir Sulfate), For HIV Positive Pregnant Women, Gets European Labeling Update Approval: Following... http://t.co/EFej2hOk
Also Shared By:
Advertisement
MNT HIV/Aids
@mnt_hivaids
Reyataz (Atazanavir Sulfate), For HIV Positive Pregnant Women, Gets European Labeling Update Approval http://t.co/lElTsjfU #hivaids
1 year ago...